Role of cyclic AMP in idiopathic nephrotic syndrome: a pathway involving a decrease in glomerular cell heparan sulfates?

Détails

ID Serval
serval:BIB_247BFC34AA2F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Role of cyclic AMP in idiopathic nephrotic syndrome: a pathway involving a decrease in glomerular cell heparan sulfates?
Périodique
Journal of Cellular Biochemistry
Auteur⸱e⸱s
Birmele  B., De Agostini  A., Girardin  E. P.
ISSN
0730-2312
Statut éditorial
Publié
Date de publication
06/2000
Peer-reviewed
Oui
Volume
78
Numéro
3
Pages
363-70
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Jun 6
Résumé
The physiopathological mechanisms of idiopathic nephrotic syndrome involve a circulating plasma factor and a decrease in HS in the glomerular basement membrane. Previous studies have demonstrated that plasma from patients with INS decreases glomerular cell HS in vitro. We examined the involvement of cyclic adenosine monophosphate (cAMP) in this interaction. We studied the effect of plasma from patients with INS on mesangial cell cAMP. We also determined mesangial cell HS when cAMP levels were modified using a cationic membrane after metabolic labeling. Cellular cAMP levels increased significantly when mesangial cells were incubated with plasma from patients with INS in comparison with control plasma (+77%, P = 0.01). Forskolin and IBMX, which increased cellular cAMP, decreased HS levels (-21 +/- 9% and -15 +/- 6% respectively, P < 0.05 for both), whereas dideoxyadenosine, which decreased cellular cAMP, increased HS levels (+24 +/- 7%, P < 0.05). Plasma from patients with INS decreased glomerular cell HS in comparison with control plasma (-34 +/- 8%, P < 0,05). This effect was abolished when cells were preincubated with ddAdo to prevent an increase in cAMP levels. We conclude that in mesangial cells, plasma from patients with INS increases cAMP levels, and that cAMP mediates a decrease in HS levels. Moreover, the action of plasma from patients on HS was inhibited when an increase in cAMP was prevented. cAMP may therefore be instrumental in the negative effect of the plasma factor on mesangial cell HS.
Mots-clé
1-Methyl-3-isobutylxanthine/pharmacology Adult Animals Antimetabolites/pharmacology Cells, Cultured Child Child, Preschool Creatinine/metabolism Cyclic AMP/*metabolism Dideoxyadenosine/pharmacology Forskolin/pharmacology Glomerular Mesangium/*metabolism Heparitin Sulfate/*biosynthesis Humans Nephrotic Syndrome/*metabolism Phosphodiesterase Inhibitors/pharmacology Plasma/physiology Rats Rats, Sprague-Dawley *Signal Transduction Statistics, Nonparametric Urine/physiology
Pubmed
Web of science
Création de la notice
15/01/2008 15:27
Dernière modification de la notice
20/08/2019 14:02
Données d'usage